Health In Tech, Inc.
HIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | 1.8% | 231.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 79.2% | 88% | 94.2% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 |
| % Margin | 5.1% | 17.7% | 3.6% |
| Other Income/Exp. Net | -$0 | $0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 |
| % Margin | 3.4% | 12.9% | 1.4% |
| EPS | 0.01 | 0.046 | 0.002 |
| % Growth | -78.2% | 2,953.3% | – |
| EPS Diluted | 0.012 | 0.046 | 0.002 |
| Weighted Avg Shares Out | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 |
| % Margin | 9.9% | 19.6% | 3.6% |